(Q77322088)

English

Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group

scientific article published on 01 September 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

open-angle glaucoma

1 reference

based on heuristic

inferred from title

author name string

L H Silver

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

American Journal of Ophthalmology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

126

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

400-408

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900095-6

7 January 2021

Carbonic anhydrase inhibitor side effects. Serum chemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900095-6

7 January 2021

Patient tolerance to carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9394(98)00095-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9744373%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77322088&oldid=1529591137"